1008562-93-3

Usage

Uses

Used in Pharmaceutical Industry:
(S)-tert-butyl 3-(methoxy(methyl)carbamoyl)piperidine-1-carboxylate is used as a building block for the synthesis of various drugs and bioactive molecules. Its unique structural features, including the tert-butyl ester group, piperidine ring, and methoxy(methyl)carbamoyl group, make it suitable for the development of potential drug candidates for a wide range of therapeutic applications.
Used in Drug Synthesis:
(S)-tert-butyl 3-(methoxy(methyl)carbamoyl)piperidine-1-carboxylate is used as a key intermediate in the synthesis of diverse compounds. Its versatility allows for the creation of new pharmaceuticals with different mechanisms of action and therapeutic targets, contributing to the advancement of medicine and healthcare.
Used in Research and Development:
(S)-tert-butyl 3-(methoxy(methyl)carbamoyl)piperidine-1-carboxylate plays a crucial role in the research and development of new pharmaceuticals. Its unique properties and structural features make it an essential component in the discovery and optimization of novel drug candidates, ultimately leading to the development of more effective treatments for various diseases and conditions.

Upstream product

• 88495-54-9 (3S)-1-(tert-butoxycarbonyl)piperidine-3-carboxylic acid 
• 1117-97-1 N,0-dimethylhydroxylamine 
• 6638-79-5 N,O-dimethylhydroxylamine*hydrochloride 

Downstream Products

• 1008563-06-1 (S)-3-acetyl-piperidine-1-carboxylic acid tert-butyl ester 
• 377780-25-1 tert-butyl (3S)-3-(1-hydroxyethyl)piperidine-1-carboxylate 
• 1235439-55-0 3-(1-amino-ethyl)-piperidine-1-carboxylic acid tert-butyl ester 
• 858643-92-2 tert-butyl 3-acetylpiperidine-1-carboxylate 

Relevant academic research and scientific papers

MORPHOLINYLBENZOTRIAZINES FOR USE IN CANCER THERAPY

The invention relates to compounds of the formula (I) in which R1, L and m have the meaning indicated in the claims, and/or physiologically acceptable salts, tautomers and stereoisomers thereof, including mixtures thereof in all ratios. The compounds of the formula (I) can be used for the inhibition of serine/threonine protein kinases and for the sensitisation of cancer cells to anticancer agents and/or ionising radiation. The invention also relates to the use of the compounds of the formula (I) in the prophylaxis, therapy or progress control of cancer, tumours, metastases or angiogenesis disorders, in combination with radiotherapy and/or an anticancer agent. The invention furthermore relates to a process for the preparation of the compounds of the formula (I) by reaction of compounds of the formulae (II) and (III) and optionally conversion of a base or acid of the compounds of the formula (I) into a salt thereof.

PIPERIDINE AMIDES AS MODULATORS OF THE GHRELIN RECEPTOR

Compounds of formula (I) or pharmaceutically acceptable salts thereof, are useful for the treatment of diabetes and obesity.

TREATMENT OF METABOLIC SYNDROME WITH CYCLIC AMIDES

The present application relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein the variables are'as defined in the claims. The present application also relates to the treatment of metabolic syndrome or disorders associated with metabolic syndrome in an affected mammal by administering a compound of formula (I) or a pharmaceutically acceptable salt thereof.